Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Wright

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist propertiesJ A Gylys, R N Wright, W D Nicolosi, et al.
Psychopharmacology Bulletin|January 1, 1990
Nefazodone: preclinical pharmacology of a new antidepressantA S Eison, M S Eison, J R Torrente, et al.
The Journal of Surgical Research|April 1, 1978
Development of a new model of subcoronary valvular aortic stenosis to create ventricular hypertrophyK O Roper, S Levitsky, M A Vorachek, et al.
Circulation|August 1, 1979
Evaluation of hypothermic cardioplegia in ventricular hypertrophyT R Coughlin, S Levitsky, M O'Donoghue, et al.
Surgery|July 1, 1977
Does intermittent coronary perfusion offer greater myocardial protection than continuous aortic cross-clamping?S Levitsky, R N Wright, K S Rao, et al.
Agents and Actions|August 1, 1987
Disease modifying activity of HWA 486 in rat adjuvant-induced arthritisR D Pasternak, N S Wadopian, R N Wright, et al.
The Journal of Clinical Psychiatry|January 1, 1995
Pharmacology and neurochemistry of nefazodone, a novel antidepressant drugD P Taylor, R B Carter, A S Eison, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist propertiesJ A Gylys, R N Wright, W D Nicolosi, et al.
Psychopharmacology Bulletin|January 1, 1990
Nefazodone: preclinical pharmacology of a new antidepressantA S Eison, M S Eison, J R Torrente, et al.
The Journal of Surgical Research|April 1, 1978
Development of a new model of subcoronary valvular aortic stenosis to create ventricular hypertrophyK O Roper, S Levitsky, M A Vorachek, et al.
Circulation|August 1, 1979
Evaluation of hypothermic cardioplegia in ventricular hypertrophyT R Coughlin, S Levitsky, M O'Donoghue, et al.
Surgery|July 1, 1977
Does intermittent coronary perfusion offer greater myocardial protection than continuous aortic cross-clamping?S Levitsky, R N Wright, K S Rao, et al.
Agents and Actions|August 1, 1987
Disease modifying activity of HWA 486 in rat adjuvant-induced arthritisR D Pasternak, N S Wadopian, R N Wright, et al.
The Journal of Clinical Psychiatry|January 1, 1995
Pharmacology and neurochemistry of nefazodone, a novel antidepressant drugD P Taylor, R B Carter, A S Eison, et al.
Pageof 3